Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Drug Information » FDA Approved Drugs » 1999
Medical Areas: Pulmonary/Respiratory Diseases

View By:YearCompanyConditionsTherapeutic AreasDrug Names

Proventil HFA Inhalation Aerosol

The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company: 3M Pharmaceuticals
Approval Status: Approved June 1999
Treatment Area: Pulmonary/Respiratory Diseases

General Information

The approval of Proventil HFA (albuterol sulfate) Inhalation Aerosol covers a supplemental new drug application that provides for the following: lowering the age from 12 years to 4 years and older for the treatment or prevention of

  • bronchospasm with reversible obstructive airway disease
  • exercise-induced bronchospasm